Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay J Mathew

Showing results (41-50 of 190) with videos related to

Pageof 19
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 11, 2019
Interactions of immediate and long-term action regulation in the course and complications of bipolar disorderMarijn Lijffijt, Brittany O'Brien, Ramiro Salas, et al.
JAMA Network Open|May 8, 2023
One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical TrialRebecca B Price, Meredith L Wallace, Sanjay J Mathew, et al.
Clinical Therapeutics|October 9, 2008
Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label studySanjay J Mathew, Amir Garakani, John F Reinhard, et al.
Pharmaceuticals (Basel, Switzerland)|September 14, 2019
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant DepressionBrittany O'Brien, Marijn Lijffijt, Allison Wells, et al.
Biological Psychiatry|June 24, 2009
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depressionRebecca B Price, Matthew K Nock, Dennis S Charney, et al.
Journal of Affective Disorders|December 31, 2017
Neurobiology of the dorsolateral prefrontal cortex in GAD: Aberrant neurometabolic correlation to hippocampus and relationship to anxiety sensitivity and IQJeremy D Coplan, Ryan Webler, Srinath Gopinath, et al.
Biological Psychiatry|June 19, 2012
Ketamine for depression: where do we go from here?Marije Aan Het Rot, Carlos A Zarate, Dennis S Charney, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 25, 2016
Heightened early-attentional stimulus orienting and impulsive action in men with antisocial personality disorderMarijn Lijffijt, Scott D Lane, Sanjay J Mathew, et al.
CNS Neuroscience & Therapeutics|March 14, 2013
The emerging use of ketamine for anesthesia and sedation in traumatic brain injuriesLee C Chang, Sally R Raty, Jaime Ortiz, et al.
Journal of Affective Disorders|June 20, 2025
Comparing the effects of ECT and intravenous ketamine in psychiatric patients with major depressive episodesJulia Myerson, Katrina A Rufino, Sanjay J Mathew, et al.
Pageof 19

Showing results (41-50 of 190) with videos related to

Sort By:
Pageof 19
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 11, 2019
Interactions of immediate and long-term action regulation in the course and complications of bipolar disorderMarijn Lijffijt, Brittany O'Brien, Ramiro Salas, et al.
JAMA Network Open|May 8, 2023
One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical TrialRebecca B Price, Meredith L Wallace, Sanjay J Mathew, et al.
Clinical Therapeutics|October 9, 2008
Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label studySanjay J Mathew, Amir Garakani, John F Reinhard, et al.
Pharmaceuticals (Basel, Switzerland)|September 14, 2019
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant DepressionBrittany O'Brien, Marijn Lijffijt, Allison Wells, et al.
Biological Psychiatry|June 24, 2009
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depressionRebecca B Price, Matthew K Nock, Dennis S Charney, et al.
Journal of Affective Disorders|December 31, 2017
Neurobiology of the dorsolateral prefrontal cortex in GAD: Aberrant neurometabolic correlation to hippocampus and relationship to anxiety sensitivity and IQJeremy D Coplan, Ryan Webler, Srinath Gopinath, et al.
Biological Psychiatry|June 19, 2012
Ketamine for depression: where do we go from here?Marije Aan Het Rot, Carlos A Zarate, Dennis S Charney, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 25, 2016
Heightened early-attentional stimulus orienting and impulsive action in men with antisocial personality disorderMarijn Lijffijt, Scott D Lane, Sanjay J Mathew, et al.
CNS Neuroscience & Therapeutics|March 14, 2013
The emerging use of ketamine for anesthesia and sedation in traumatic brain injuriesLee C Chang, Sally R Raty, Jaime Ortiz, et al.
Journal of Affective Disorders|June 20, 2025
Comparing the effects of ECT and intravenous ketamine in psychiatric patients with major depressive episodesJulia Myerson, Katrina A Rufino, Sanjay J Mathew, et al.
Pageof 19